Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a
Clinical trial NCT01514370 · COMPLETED
Trial details
- NCT number
- NCT01514370
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-30
- Primary completion
- 2016-03-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.